Reproductive Genetics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Component (Laboratory Developed Tests, Kits & Assays, Reagents & Consumables), By Technology (Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, Microarrays), By Procedure Type (Carrier Screening, Prenatal Screening, Preimplantation Genetic Testing, Infertility Genetic Testing), By Application (Aneuploidy, Single Gene Disorder, Structural Chromosomal Abnormality, Others), By Region and Competition

The global reproductive genetics market is anticipated to witness an impressive growth during the forecast period. This can be ascribed to the growing awareness towards genetic engineering in the developing countries, to get better. Additionally, growing reimbursement improvements for medical tests and initiative, running parallel to multiple investments by government organizations for developing new diagnostic centers, have significantly increased the demand for reproductive genetics across different parts of the globe. Additionally, significant growth in advanced testing along with increasing awareness among different age group women for leading  safe life, are further expected to increase the demand for reproductive genetics, thereby fuelling the market growth through 2027. Furthermore, increasing focus on family planning, favorable regulations by the government, and advancements in different testing are further expected to increase the demand for reproductive genetics, thereby supporting the market growth. Similarly, advancement in geno9mic technologies and implementation of this technology in clinical medicine will enhance the usage in genetic disorder testing, carrier screening and identification of infertility which will further boost the growth of the market during the forecast period.

Increasing demand for Genetic Testing

Increasing demand for genetic testing of embryos, either during pregnancy or of those created through IVF to check for possible genetic disorders, are driving growth of reproductive genetics market. Increasing genetic testing for embryos through IVF technology, and several developments in genetic testing are making it possible to test for genetic disorders in artificial reproduction, which is driving the market growth during the forecast period.  Reproductive genetics help to identify embryo’s defects so that parents can adopt alternative procedure like IVF thus increasing the healthy pregnancy and baby regardless of patient health, which will further boost the market during forecast period. According to Statista, as of 2019, the leading state by number of legal abortions in the United States was New York, which reported over 78 thousand abortions that year. Florida also reported over 71 thousand abortions, followed by Texas with over 57 thousand. There was a total of 630000 legal abortions in the United States in 2019.

Growing Advancement in Genomic Technologies

Increasing advancement in genomic technologies and further implementation of these technologies in clinical medicine have enhanced their usage in diagnosis of genetic disorders, carrier screening, and identification of cause of infertility, propelling the market growth in the forecast period. Some tests are much expensive which help couples from going ahead with the tests. However, with the decline in cost of sequencing and surge in mixed-ethnicity population, an increasing number of couples/individuals are expected to opt for the new procedure, which expected to drive the market growth during forecast period. Birth defects affect one in every 33 babies (about 3% of all babies) born in the United States each year.

Download Free Sample Report 

Market Segmentation

The global reproductive genetics market can be segmented by component, by technology, by procedure type, by application and by region. Based on component, the market can be segmented into Laboratory Developed Tests, Kits & Assays, and Reagents & Consumables. Based on technology, the market can be segmented into Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, and Microarrays. Based on procedure type, the market can be differentiated into Carrier Screening, Prenatal Screening, Preimplantation Genetic Testing, and Infertility Genetic Testing. Based on application, the market can be grouped into Aneuploidy, Single Gene Disorder, Structural Chromosomal Abnormality, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, United States dominated the global reproductive genetics market on account of increasing demand for genetic testing to identify genetic abnormalities in the country.

Recent Development.

• In May 2021, Juno Diagnostics, Which is a company focusing on enhancing access to genetic health information, announced that closing of Series A financing round for USD 25 million led by Perceptive Xontogeny Venture (PXV) Fund. The fund will support product development, clinical validation studies, and commercial launch of JunoDx’s product offerings for non-invasive prenatal testing.
• In March 2020, Agilent Technology announced the launch of three new microarrays for prenatal and postnatal research. The microarray includes updated clinically relevant content from respected databases. Progression of next-generation sequencing is uncovering new gene-disease associations and databases are rapidly evolving to include these discoveries. 

· 

 Market Players

CooperSurgical, Inc., Centogene AG, Invitae Corporation, Illumina, Inc., Myriad Genetics, Inc., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics, Natera, Inc, Eurofins Scientific SE are some of the leading players operating in the Global Reproductive Genetics Market.

Report Scope:

In this report, global reproductive genetics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         Reproductive Genetics Market, By Component:

o      Laboratory Developed Tests

o      Kits & Assays

o      Reagents & Consumables

·         Reproductive Genetics Market, By Technology:

o      Next Generation Sequencing

o      Polymerase Chain Reaction

o      In Situ Hybridization, Microarrays

·         Reproductive Genetics Market, By Procedure Type:

o      Carrier Screening

o      Prenatal Screening

o      Preimplantation Genetic Testing

o      Infertility Genetic Testing

·         Reproductive Genetics Market, By Application:

o      Aneuploidy

o      Single Gene Disorder

o      Structural Chromosomal Abnormality

o      Others

·         Reproductive Genetics Market, By Region:

o      North America

§  United States

§  Canada

§  Mexico

o      Europe

§  France

§  Germany

§  United Kingdom

§  Italy

§  Spain

o      Asia Pacific

§  China

§  India

§  Japan

§  South Korea

§  Australia

o      South America

§  Brazil

§  Argentina

§  Colombia

o      Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

§  Turkey

§  Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Reproductive Genetics Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Reproductive Genetics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]